Results 221 to 230 of about 349,413 (344)

Metabolic syndrome and ADRB3 gene polymorphism in severely obese patients from South Italy [PDF]

open access: yes, 2007
C Finelli   +9 more
core  

Which Patients With Dysfunctional Voiding Respond Well to Sacral Neuromodulation? ICI‐RS 2025

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims Dysfunctional voiding (DV) is characterised by fluctuating or intermittent urinary flow during voiding in neurologically normal individuals. Given the different definitions used and heterogeneous pathophysiologies, outcomes following sacral neuromodulation/sacral nerve stimulation (SNM/SNS) are variably reported.
Jalesh N. Panicker   +8 more
wiley   +1 more source

Thermogenic Targets for Obesity Management in the Era of Incretin-Based Therapies. [PDF]

open access: yesPharmaceuticals (Basel)
Soliman S   +3 more
europepmc   +1 more source

Phenotyping Overactive Bladder—Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI‐RS 2025

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Overactive bladder (OAB) is defined as urinary urgency, usually accompanied by increased daytime frequency and/or nocturia, with urgency urinary incontinence (OAB‐wet) or without (OAB‐dry), in the absence of urinary tract infection or other detectable disease.
John E. Speich   +9 more
wiley   +1 more source

The alpha 1-adrenergic agonist methoxamine and the "loop" diuretic frusemide reduce nasal potential difference [PDF]

open access: bronze, 1991
AM Wood   +4 more
openalex   +1 more source

Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Purpose Vibegron was associated with improvements in efficacy versus placebo and was well tolerated in men with overactive bladder (OAB) on pharmacotherapy for benign prostatic hyperplasia (BPH) in the COURAGE trial (NCT03902080). Additional safety, bladder function, and urodynamics data are provided.
Eric S. Rovner   +6 more
wiley   +1 more source

Impact of physical and psychological stressors on tumor growth and immune responses in breast cancer. [PDF]

open access: yesCompr Psychoneuroendocrinol
Dees K   +10 more
europepmc   +1 more source

Association of obesity and body mass index classification with glycemic control in adults who are critically ill receiving parenteral nutrition: A retrospective study

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background Hyperglycemia is a complication of parenteral nutrition (PN), which can be exacerbated in patients with obesity. Limited data exist on glycemic control in this population. This study aims to evaluate the association of obesity and body mass index (BMI) classification with glycemic control in patients who are critically ill initiated
Erika L. Mackie   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy